Article PDF
Rights and permissions
About this article
Cite this article
Glaser, V. Clinical costs escalate biotechnology's R&D expenses. Nat Biotechnol 14, 937 (1996). https://doi.org/10.1038/nbt0896-937
Issue Date:
DOI: https://doi.org/10.1038/nbt0896-937